Xiang Wang

13.0k citations
407 papers · 9.5k · 5 hit papers · h-index 43

Impact in

    • Cancer-related molecular mechanisms research
    • Breast Cancer Treatment Studies
    • MicroRNA in disease regulation
  • Oncology top 2%

Papers in

    • Cancer-related molecular mechanisms research 35
    • Breast Cancer Treatment Studies 24
    • MicroRNA in disease regulation 21
    • Protease and Inhibitor Mechanisms 11
    • Cancer Cells and Metastasis 13

Xiang Wang

385 papers receiving 9.4k citations

Xiang Wang's Hit Papers

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials 2021 · 241 citations
2410+3+6Years since publication250500750

Peers

Xiang Wang
Comparison fields: 5 of 175
  • Cancer Research 2.8k
  • Oncology 1.6k
  • Molecular Biology 3.2k
  • Pulmonary and Respiratory Medicine 1.1k
  • Hematology 400
Replace Agnes Jager with:
Agnes Jager Netherlands
Timothy O’Brien Ireland
Núria Malats Spain
Imo E. Hoefer Netherlands
Yon‐Dschun Ko Germany
Peter A. Johansson United States
Riccardo Vigneri Italy
Li Su China
Nikos Werner Germany
Paolo Giovanni Vigneri Italy
Xiang Wang relative to Agnes Jager Netherlands Agnes Jager's profile →
Citations per field
00.5×2×2.9×
Agnes Jager · 1×
Citations per year

Countries citing papers authored by Xiang Wang

Since Specialization
Citations

This map shows the geographic impact of Xiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Wang more than expected).

Fields of papers citing papers by Xiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Wang. The network helps show where Xiang Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiang Wang Line = papers co-authored together Xiang Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 407 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Hit paper breakdown →
2017844
2
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53
Hit paper breakdown →
2018420
3
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2019316
4 2019306
5
Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1
Hit paper breakdown →
2017294
6
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Hit paper breakdown →
2021241
7 2014230
8 2014204
9 2011181
10 2022117
11 2018110
12 2018109
13 2010106
14 202395
15 202092
16 202192
17 202089
18 200988
19 200185
20 201080

About Xiang Wang

Xiang Wang is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 407 papers that have together received 9.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (35 papers), Breast Cancer Treatment Studies (24 papers), MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (15 papers), RNA modifications and cancer (14 papers), Cancer Cells and Metastasis (13 papers), Protease and Inhibitor Mechanisms (11 papers) and Cell Adhesion Molecules Research (10 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (1.6k citations), Molecular Biology (3.2k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Hematology (400 citations). Xiang Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Carlos Fernández-Patrón, Xiaosu Zhao, Ying Bao, Phillip Chung-Ming Yang, Zamaneh Kassiri, Fung Lan Chow, Yongguang Tao, Ruiqi Wang, Xu Li and Jingjing Pan. Their work appears in journals such as Frontiers in Oncology, Oncotarget, Medicine, Journal of Cellular and Molecular Medicine and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact